Login to Your Account

San Antonio Breast Cancer Symposium

Positive Breast Cancer Study Boosts Celldex Therapeutics

By Peter Winter
BioWorld Insight Editor

Tuesday, December 11, 2012
Shares of Celldex Therapeutics Inc. gained 25.5 percent Monday – a reaction to the company reporting positive final data on CDX-011 in a Phase II study in metastatic breast cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription